Announced Fri, 26 Jun · 15:48 IST
Trading Window Closure from July 1 Ahead of Q1 Results
Compliance View source PDF
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+5.0%1-day move
₹1270.40
prior close
₹1269.20
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.7+0.5+0.8+3.7+5.0+3.1+5.1+9.3+6.4+12.2+9.2———
Up moveDown movePending
AI summary
Senores Pharmaceuticals has informed the exchanges that its insider trading window will be closed from July 1, 2026, until 48 hours after the announcement of unaudited financial results for the quarter ending June 30, 2026. The closure covers directors, promoters, designated persons and their immediate relatives. This is a routine compliance filing under SEBI insider trading rules ahead of Q1 FY27 earnings. The board meeting date to approve the results will be communicated separately.
Likely market impact
Routine compliance filing ahead of quarterly results. No direct impact on shareholders, but signals the upcoming Q1 earnings release.